Vaborbactam | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vaborbactam
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Vaborbactam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities

7 US Patents
2 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 7REMPEX

filter Patent Number Reset all filters

7 All

01 18680136

02 19694025

03 110172874

04 110183034

05 110561675

06 111007206

07 111376237

filter API Patent Reset all filters

7 All

01 1Y

02 6Blank

filter FDF Patent Reset all filters

7 All

01 2Y

02 5Blank

filter Expiration Date Reset all filters

7 All

01 52031-08-08

02 12031-08-29

03 12039-04-06

Product Main Page

01

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 9694025

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2120

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10561675

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-06

MEROPENEM; VABORBACTAM

US Patent Number : 11376237

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3421

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-06

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10183034

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 11007206

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3128

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-29

MEROPENEM; VABORBACTAM

US Patent Number : 8680136

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-29

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

07

REMPEX

MEROPENEM; VABORBACTAM

2024 ACI Convention

Not Confirmed

REMPEX

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10172874

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?